Skip to content
Daily Issue
Future
of Work
·
Sign in
Daily Issue → inbox:
Subscribe
F
Feed
E
Explore
B
Build
R
Roles
A
Alerts
Y
You
●
Last issue 5d ago
← Back to explore
Celea Therapeutics
Follow
Pharmaceuticals
Advance deupirfenidone for IPF (idiopathic pulmonary fibrosis).
Funding Timeline
7/3/2026
unknown
$180M
Celea Therapeutics | Funded Work